Cargando…

Eculizumab for pediatric dense deposit disease: A case report and literature review

Dense deposit disease (DDD), a subtype of complement component 3 (C3) glomerulopathy (C3G), results from alternative complement pathway hyperactivity leading to membrane attack complex formation. DDD treatment strategies are limited. We report a case of a 13-year-old girl diagnosed with DDD at 9 yea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasahara, Katsuaki, Gotoh, Yoshimitsu, Majima, Hisakazu, Takeda, Asami, Mizuno, Masashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dustri-Verlag Dr. Karl Feistle 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737524/ https://www.ncbi.nlm.nih.gov/pubmed/33329990 http://dx.doi.org/10.5414/CNCS110309

Ejemplares similares

Warfarin-induced toxic epidermal necrolysis in combination therapy of Henoch-Schönlein purpura nephritis: a case report
por: Kasahara, Katsuaki, et al.
Publicado: (2017)

Eculizumab for the Treatment of Severe Antibody-Mediated Rejection: A Case Report and Review of the Literature
por: Tran, Duy, et al.
Publicado: (2016)

Cardiac Tamponade-Associated Dense Deposit Disease: A Case Report and Review of the Literature
por: Al Zabali, Saeed M, et al.
Publicado: (2022)

Eculizumab: COVID-19: case report
Publicado: (2021)

Can eculizumab be discontinued in aHUS?: Case report and review of the literature
por: Sahutoglu, Tuncay, et al.
Publicado: (2016)

A long history of dense deposit disease
por: Cunningham, Alan, et al.
Publicado: (2018)

Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report
por: Facchini, Ludovica, et al.
Publicado: (2017)

Eculizumab treatment for renal failure in a pediatric patient with COVID-19
por: Mahajan, Ruchi, et al.
Publicado: (2020)

Eculizumab/tocilizumab: Various toxicities: case report
Publicado: (2020)

36-Year-Old Female with Catastrophic Antiphospholipid Syndrome Treated with Eculizumab: A Case Report and Review of Literature
por: Strakhan, Marianna, et al.
Publicado: (2014)

Increased eculizumab requirements during pregnancy in a patient with paroxysmal nocturnal hemoglobinuria: case report and review of the literature
por: Patriquin, Christopher, et al.
Publicado: (2015)

Maintenance eculizumab dose adjustment in the treatment of atypical hemolytic uremic syndrome: a case report and review of the literature
por: Thomson, Nick, et al.
Publicado: (2016)

Eculizumab application during pregnancy in a patient with paroxysmal nocturnal hemoglobinuria: A case report with review of the literature
por: Lauritsch‐Hernandez, Lisa Sophie, et al.
Publicado: (2018)

Disseminated Gonococcal Infection Associated with Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria: A Case Report and Literature Review
por: Saito, Makoto, et al.
Publicado: (2020)

Eculizumab Dosing in Infants
por: Kobrzynski, M., et al.
Publicado: (2018)

Dense Deposit Disease Involving C3 and C4d Deposits
por: Vankalakunti, M., et al.
Publicado: (2018)

Blockade of Alternative Complement Pathway in Dense Deposit Disease
por: Berthe-Aucejo, Aurore, et al.
Publicado: (2014)

A Case Report and Literature Review of Eculizumab Withdrawal in Atypical Hemolytic-Uremic Syndrome
por: Quiroga, Borja, et al.
Publicado: (2016)

A case of dense pigment deposition of the posterior lens capsule
por: Trampuž, Igor Šivec
Publicado: (2020)

Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance
por: Ito, Shuichi, et al.
Publicado: (2018)

Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report
por: Hirashio, Shuma, et al.
Publicado: (2018)

Eculizumab in chemotherapy-induced thrombotic microangiopathy
por: Schulte-Kemna, Lena, et al.
Publicado: (2020)

A case of regression of atypical dense deposit disease without C3 deposition in a child
por: Kim, Min Sun, et al.
Publicado: (2010)

Anticoagulants/eculizumab/elasomeran: Various toxicities and lack of efficacy: case report
Publicado: (2022)

Eculizumab: Lack of efficacy following off-label use: case report
Publicado: (2021)

Gemcitabine-induced thrombotic microangiopathy treated with eculizumab: a case report
por: Van den Eeckhaut, Lisa, et al.
Publicado: (2022)

Use of Eculizumab in Pediatric Patients With Transplant Associated Thrombotic Microangiopathy
por: Gomez-Ganda, Laura, et al.
Publicado: (2021)

Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab
por: Wijnsma, Kioa Lente, et al.
Publicado: (2019)

A rare case of proliferative glomerulonephritis with monoclonal IgG2 kappa deposit: a case report
por: Ito, Daisuke, et al.
Publicado: (2022)

Eculizumab for refractory thrombosis in antiphospholipid syndrome
por: Hussain, Habiba, et al.
Publicado: (2022)

Podocytes Intracytoplasmic Dense Inclusions: Are They Associated with Subepithelial Dense Deposits? An Ultrastructural Study
por: Jalalah, Sawsan Mohammad
Publicado: (2020)

Childhood-onset dense deposit disease: a rare cause of proteinuria
por: Taranta-Janusz, K., et al.
Publicado: (2013)

The use of eculizumab in gemcitabine induced thrombotic microangiopathy
por: Krishnappa, Vinod, et al.
Publicado: (2018)

The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy
por: Gabr, Jihad Ben, et al.
Publicado: (2020)

A CHILD WITH DENSE DEPOSIT DISEASE AND DECREASED CLASSIC COMPLEMENT PATHWAY ACTIVITY
por: Trutin, Ivana, et al.
Publicado: (2021)

Monoclonal IgG4/2κ Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney Transplantation
por: Singh, Priyamvada, et al.
Publicado: (2019)

The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
por: Bjørkto, Magnus Holter, et al.
Publicado: (2021)

Dense Deposit Disease and C3 Glomerulopathy
por: Barbour, Thomas D., et al.
Publicado: (2013)

Early treatment with eculizumab in atypical haemolytic uraemic syndrome
por: Garjau, Maria, et al.
Publicado: (2012)

Eculizumab: A Review in Generalized Myasthenia Gravis
por: Dhillon, Sohita
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cmds7tl79l3403tuit9nbg93n7